WSA
DVAX

Wall Street Associates’s Dynavax Technologies DVAX Stock Holding History

Wall Street Associates’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-27,300
Closed -$660K – 232
2015
Q4 		$660K Sell
27,300
-12,612
-32% -$316K 0.19% 178
2015
Q3 		$979K Buy
+39,912
New +$1.13M 0.19% 150

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wall Street Associates's DVAX Position: Q1 2016 in Review

Wall Street Associates sold out of Dynavax Technologies (DVAX) in Q1 2016, closing a stake of 27,300 shares — an estimated $660K sold.

Wall Street Associates first reported a position in DVAX in Q3 2015 and held it in 2 quarters. The position peaked at $979K in Q3 2015. 130 funds tracked by Wall St. Rank hold DVAX as of Q1 2016.

  • Wall Street Associates reported no remaining Dynavax Technologies position as of Q1 2016 after selling out during the quarter.
  • Wall Street Associates sold 27,300 Dynavax Technologies shares in Q1 2016, an estimated $660K.
  • Wall Street Associates first reported a position in Dynavax Technologies in Q3 2015 and held it in 2 quarters.
  • Wall Street Associates's Dynavax Technologies position peaked at $979K in Q3 2015.
  • 130 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2016.

Based on Wall Street Associates's 13F filing for Q1 2016, filed 13 May 2016.